VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety. VUNO Med®-Fundus AI™ is the first ever AI device to gain a Class III approval in Korea and is clinically validated to provide highly accurate screening results. According to the research paper published in Ophthalmology, one of the most prestigious

Abbott announced that its TriClip™ Transcatheter Tricuspid Valve Repair System has received CE Mark and is now approved for use in Europe and other countries that recognize CE Mark as a non-surgical treatment for people with a leaky tricuspid valve, a condition known as tricuspid regurgitation (TR). With the CE Mark designation, Abbott's TriClip device is the first minimally invasive, clip-based tricuspid valve repair device to be commercially available in the world. Abbott is a glo

NEW YORK, March 4, 2020 /PRNewswire/ -- Corporate Insight, the leading provider of competitive intelligence and user experience research, today announced the release of its new Medicare Monitor. This service benchmarks all aspects of the digital user experience for Medicare plan prospects and members, from account opening and onboarding to the secure customer web an

SHANGHAI, March. 4, 2020 /PRNewswire/ -- Luye Pharma Group has announced that the U.S. Food and Drug Administration (FDA) has reviewed and accepted the filing of a New Drug Application (NDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. LY03005 is the company's second drug in the central nervous system (CNS) therapeutic area currently in the U.S. FDA's NDA phase.

NEW YORK, March 4, 2020 /PRNewswire/ -- On Tuesday, March 3, 2020, the Pasteur Foundation US honored three individuals with its prestigious awards during a special gala. Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, received the inaugural L

CONCORD, Mass., March 4, 2020 /PRNewswire/ -- Alopexx Oncology, LLC announced today that it has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.  Alopexx will receive an upfront payment, various

TeraRecon will accelerate innovation in its advanced visualization and AI platforms for image-related decision support to clinical specialists LOS ALTOS, Calif. and DURHAM, N.C., March 4, 2020 /PRNewswire/ -- SymphonyAI Group, an operating group of leading business-to-business AI companies, today announced th

RICHMOND, Va., March 4, 2020 /PRNewswire/ -- The Virginia Center for Addiction Medicine, a premier outpatient addiction treatment center, announced today that it has appointed Dr. Andreas Bienert as its clinical program director. Bienert will join Anna McKean, who was recently appointed as the chief

PLANO, Texas, March 4, 2020 /PRNewswire/ -- Vivify Health, the developer of the nation's leading connected care platform for holistic patient care and engagement, today announced the availa

TIOGA, Texas, March 4, 2020 /PRNewswire/ -- Healing Springs Ranch (HSR), an internationally recognized residential treatment center known for its integrative work with adults recovering from ALL addictions (both process and substance) trauma, and all related mental health symptoms proudly announces the appointment of Julie Willingham